Abstract:Burkholderia pseudomallei (Bp) is an environmental bacterial pathogen that causes potentially lethal sepsis in susceptible individuals and is considered a Category B, Tier-1 biothreat agent. As such, it is crucial to gain an improved understanding of protective immunity and potential vaccine candidates. The nature of immune correlates dictating why most exposed individuals in endemic regions undergo asymptomatic seroconversion while others succumb to life-threatening sepsis is largely uncharted. Bp seroreactiv… Show more
“…Cell-mediated immune responses by IFN-γ and type I immune responses (e.g., interleukin [IL] 12, IL-18, tumor necrosis factor α) are essential for the host immune system in fighting against intracellular infections (29)(30)(31). Nithichanon et al showed that most of an exposed healthy population has acquired cellular immunity against broad immunogenic B. pseudomallei epitopes (32). Our IFN-γ ELISpot experiments suggest that both melioidosis patients and HH contacts engage strong cross-immune IFN-γ responses between B. pseudomallei, B. thailandensis, and BTCV, despite low humoral responses in the HH cohort.…”
“…Cell-mediated immune responses by IFN-γ and type I immune responses (e.g., interleukin [IL] 12, IL-18, tumor necrosis factor α) are essential for the host immune system in fighting against intracellular infections (29)(30)(31). Nithichanon et al showed that most of an exposed healthy population has acquired cellular immunity against broad immunogenic B. pseudomallei epitopes (32). Our IFN-γ ELISpot experiments suggest that both melioidosis patients and HH contacts engage strong cross-immune IFN-γ responses between B. pseudomallei, B. thailandensis, and BTCV, despite low humoral responses in the HH cohort.…”
“…NanoRPLC-MS/MS was utilized in this study to identify proteins produced by B. pseudomallei while inside murine macrophages. The intracellular protein profile closely resembled the gene expression of B. pseudomallei in vivo, especially as described for human immune responses characterized using sera from patients infected with B. pseudomallei [25,26,[28][29][30][31][32][45][46][47][48]. We predicted that previously characterized Burkholderia proteins would be identified and serve as a positive control for our technical approach.…”
Section: Discussionmentioning
confidence: 74%
“…B. pseudomallei AhpC was found to be highly expressed in plasma from melioidosis survivors, but not in healthy controls [31]. In addition, T cell mediated immunity to AhpC was associated with protection against disease and shown to be a correlate of survival [46,48] and it represents a melioidosis vaccine candidate [30,46,48]. BPSL2748 is a putative AhpC-type peroxiredoxin, but it has not been as extensively studied as B. pseudomallei AhpC.…”
Section: Discussionmentioning
confidence: 99%
“…The bacterial heat shock proteins (HSPs) detected inside macrophages included the chaperones GroES, GroEL, HtpG, DnaK and GrpE (Table 1). These proteins are highly conserved proteins but have been shown to have important roles in infection, and in the immune response to and diagnosis of infection [25][26][27][28][29][30][31][32][33]. Additional intracellularly produced bacterial proteins associated with host-mediated nutritional and oxidative stress included the universal stress protein A (UspA), peroxiredoxin BPSL2748 and superoxide dismutase BPSL0880 (SodB).…”
Section: One Hundred Sixty B Pseudomallei Proteins Identified Insidementioning
Burkholderia pseudomallei: is the etiological agent of the disease melioidosis and is a Tier 1 select agent. It survives and replicates inside phagocytic cells by escaping from the endocytic vacuole, replicating in the cytosol, spreading to other cells via actin polymerization and promoting the fusion of infected and uninfected host cells to form multinucleated giant cells. In this study, we utilized a proteomics approach to identify bacterial proteins produced inside RAW264.7 murine macrophages and host proteins produced in response to B. pseudomallei infection. Cells infected with B. pseudomallei strain K96243 were lysed and the lysate proteins digested and analyzed using nanoflow reversed-phase liquid chromatography and tandem mass spectrometry. Approximately 160 bacterial proteins were identified in the infected macrophages, including BimA, TssA, TssB, Hcp1 and TssM. Several previously uncharacterized B. pseudomallei proteins were also identified, including BPSS1996 and BPSL2748. Mutations were constructed in the genes encoding these novel proteins and their relative virulence was assessed in BALB/c mice. The 50% lethal dose for the BPSS1996 mutant was approximately 55-fold higher than that of the wild type, suggesting that BPSS1996 is required for full virulence. Sera from B. pseudomallei-infected animals reacted with BPSS1996 and it was found to localize to the bacterial surface using indirect immunofluorescence. Finally, we identified 274 host proteins that were exclusively present or absent in infected RAW264.7 cells, including chemokines and cytokines involved in controlling the initial stages of infection.
“…Epitope identification is expensive and laborious, requiring experimental screening of large arrays of potential epitope candidates. However, recent works of epitope mapping of Burkholderia strains have been performed using the peptide microarray approach [ 59 , 60 , 61 ]. This technique relies on the use of libraries of synthesized linear peptides spotted on a single chip and screening for antigenicity using patients’ antisera.…”
Section: Bioinformatics Tools To Predict Immunogenic Epitopesmentioning
Bacteria of the Burkholderia cepacia complex (Bcc) remain an important cause of morbidity and mortality among patients suffering from cystic fibrosis. Eradication of these pathogens by antimicrobial therapy often fails, highlighting the need to develop novel strategies to eradicate infections. Vaccines are attractive since they can confer protection to particularly vulnerable patients, as is the case of cystic fibrosis patients. Several studies have identified specific virulence factors and proteins as potential subunit vaccine candidates. So far, no vaccine is available to protect from Bcc infections. In the present work, we review the most promising postgenomic approaches and selected web tools available to speed up the identification of immunogenic proteins with the potential of conferring protection against Bcc infections.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.